济川药业：11月24日召开董事会会议

Group 1 - The core point of the article is that Jichuan Pharmaceutical (SH 600566) announced its board meeting and provided a breakdown of its revenue composition for 2024, along with its current market capitalization of 23.8 billion yuan [1][1][1] Group 2 - Jichuan Pharmaceutical's revenue composition for 2024 is as follows: 33.53% from heat-clearing and detoxifying products, 28.11% from pediatric products, 14.41% from digestive products, 9.94% from other industries, and 8.13% from respiratory products [1][1][1] - As of the report, Jichuan Pharmaceutical's market capitalization stands at 23.8 billion yuan [1][1][1]